All Stories

  1. From Natural Xanthones to Synthetic C-1 Aminated 3,4-Dioxygenated Xanthones as Optimized Antifouling Agents

    Article • Marine Drugs, November 2021, MDPI AG

    Agostinho Lemos

  2. Oxygenated xanthones as P-glycoprotein modulators at the intestinal barrier: in vitro and docking studies

    Article • Medicinal Chemistry Research, April 2020, Springer Science + Business Media

    Agostinho Lemos

  3. An Overview of Antiretroviral Agents for Treating HIV Infection in Paediatric Population

    Article • Current Medicinal Chemistry, March 2020, Bentham Science Publishers

    Agostinho Lemos, Beatriz Bueschbell

  4. Radical C–H 18F-Difluoromethylation of Heteroarenes with [18F]Difluoromethyl Heteroaryl-Sulfones by Visible Light Photoredox Catalysis

    Article • Catalysts, March 2020, MDPI AG

    Agostinho Lemos

  5. Development of a General Automated Flow Photoredox 18F-Difluoromethylation of N-Heteroaromatics in an AllinOne Synthesizer

    Article • Organic Process Research & Development, February 2020, American Chemical Society (ACS)

    Agostinho Lemos

  6. Late stage 18F-difluoromethyl labeling of N-heteroaromatics with high molar activity for PET imaging

    Article • Angewandte Chemie International Edition, July 2019, Wiley

    Agostinho Lemos

  7. Synthesis, Biological Evaluation, and In Silico Studies of Novel Aminated Xanthones as Potential p53-Activating Agents

    Article • Molecules, May 2019, MDPI AG

    Agostinho Lemos

  8. Newly Synthesized Oxygenated Xanthones as Potential P-Glycoprotein Activators: In Vitro, Ex Vivo, and In Silico Studies

    Article • Molecules, February 2019, MDPI AG

    Agostinho Lemos

  9. Progress in Difluoroalkylation of Organic Substrates by Visible Light Photoredox Catalysis

    Article • Advanced Synthesis & Catalysis, January 2019, Wiley

    Agostinho Lemos

  10. New inhibitor of the TAp73 interaction with MDM2 and mutant p53 with promising antitumor activity against neuroblastoma

    Article • Cancer Letters, January 2019, Elsevier

    Agostinho Lemos

  11. Computational Approaches in Antibody-drug Conjugate Optimization for Targeted Cancer Therapy

    Article • Current Topics in Medicinal Chemistry, October 2018, Bentham Science Publishers

    ozge sensoy, Agostinho Lemos

  12. P-gp induction and activation as a potential therapeutic approach in intoxications and/or neurological diseases–in vitro and in silico studies

    Article • Toxicology Letters, October 2018, Elsevier

    Agostinho Lemos

  13. In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson’s Disease

    Article • Current Neuropharmacology, June 2018, Bentham Science Publishers

    Professor Maria Natália DS Cordeiro, Agostinho Lemos, M. Natalia D. S. Cordeiro

  14. Computer-Aided Drug Design Approaches to Study Key Therapeutic Targets in Alzheimer’s Disease

    Article • September 2017, Springer Science + Business Media

    Agostinho Lemos, M. Natalia D. S. Cordeiro

  15. Hit optimization of newly synthetized xanthonic derivatives as P-gycoprotein modulators – In silico and in vitro studies

    Article • Toxicology Letters, September 2016, Elsevier

    Agostinho Lemos

  16. Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction

    Article • Medicinal Research Reviews, June 2016, Wiley

    Agostinho Lemos